Ads
related to: what is brca1- BRCA Testing Information
Get Info On BRCA Gene Testing And
More On A Dosing Option.
- BRCA & HRD Testing
Get Info On BRCA & HRD Testing And
Screening Option For Your Patients
- Ovarian Cancer Support
Access Support Resources For
Patients. Learn More Today.
- Guidelines
Learn About Treatment Guidelines
For Ovarian Cancer Patients.
- Official Physician Site
See About A Treatment For Advanced
Ovarian Cancer.
- Important Safety Info
Read Safety Information For A
Treatment Option For Advanced OC.
- BRCA Testing Information
Search results
Results From The WOW.Com Content Network
High BRCA1 may protect cancer cells by acting in a pathway that removes the damages in DNA introduced by the platinum drugs. Thus the level of BRCA1 expression is a potentially important tool for tailoring chemotherapy in lung cancer management. [123] [124] Level of BRCA1 expression is also relevant
Inheriting one BRCA1 mutation and one BRCA2 mutation has been reported occasionally; the child's risk for any given type of cancer is the higher risk of the two genes (e.g., the ovarian cancer risk from BRCA1 and the pancreatic cancer risk from BRCA2). Inheriting two BRCA2 mutations produces Fanconi anemia. [9]: 82–85
BRCA1 C Terminus (BRCT) domain is a family of evolutionarily related proteins. It is named after the C-terminal domain of BRCA1 , a DNA-repair protein that serves as a marker of breast cancer susceptibility.
"It's very rare for a BRCA1 carrier to have breast cancer younger than age 25," Nicolette Chun, a genetics counselor at the Stanford Cancer Institute, said. "If there is a family history of breast ...
675 12190 Ensembl ENSG00000139618 ENSMUSG00000041147 UniProt P51587 P97929 RefSeq (mRNA) NM_000059 NM_001081001 NM_009765 RefSeq (protein) NP_000050 NP_001074470 NP_033895 Location (UCSC) Chr 13: 32.32 – 32.4 Mb Chr 5: 150.45 – 150.49 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse BRCA2 and BRCA2 are human genes and their protein products, respectively. The official symbol ...
Breast and ovarian cancers: Medicare may cover genetic testing to determine if a person has a mutation in the BRCA1 and BRCA2 genes, which can help identify their risk of breast and ovarian cancers.
Mary-Claire King (born February 27, 1946) [1] is an American geneticist.She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1.
People with BRCA1 and BRCA2 mutations are recommended to have a transvaginal ultrasound 1-2 times per year. Screening with CA-125 is also recommended.. Prophylactic salpingo-oophorectomy (removal of the ovaries and fallopian tubes to prevent cancer) is recommended at age 35-40 for people with BRCA1 mutations and at age 40-45 for people with BRCA2 mutations. [6]
Ads
related to: what is brca1